The Comparative Effectiveness of Natalizumab and Anti-CD20 Monoclonal Antibodies in Relapsing-Remitting Multiple Sclerosis: A Real-World based Study

被引：0

作者：

Zeineddine, Maya ^{[1
,2
]}

Alroughani, Raed ^{[3
]}

Mohamed, Samar Farouk Ahmed ^{[4
]}

Al Mahdawi, Akram ^{[5
]}

Khoury, Samia ^{[6
]}

El Ayoubi, Nabil ^{[6
]}

Inshasi, Jihad ^{[7
,8
]}

Al Khaboori, Jaber ^{[9
]}

Al-Asmi, Abdullah ^{[10
,11
]}

Gouider, Riadh ^{[12
]}

Aljarallah, Salman ^{[13
]}

Al Khawajah, Nuha Marwan ^{[13
]}

Al Malik, Yaser ^{[14
,15
]}

Abulaban, Ahmad ^{[14
,15
]}

Makkawi, Seraj ^{[14
,15
,16
]}

Khojah, Osama ^{[14
,15
,16
]}

El Hajj, Taghrid ^{[17
]}

Massouh, Joelle ^{[18
]}

Alsalamat, Husam ^{[19
]}

Dimassi, Hani ^{[2
]}

al-hajje, Amal ^{[20
,21
]}

Salameh, Pascale ^{[20
,21
,22
,23
]}

Boumediene, Farid ^{[1
]}

Yamout, Bassem I. ^{[18
]}

机构：

[1] Univ Limoges, CHU Limoges, Inserm,Inst Epidemiol & Trop Neurol,Omega Hlth, U1094,IRD U270,EpiMaCT Epidemiol Chron Dis Trop Z, Limoges, France

[2] Lebanese Amer Univ, Sch Pharm, Byblos, Lebanon

[3] Amiri Hosp, Kuwait, Kuwait

[4] Ibn Sina Hosp, Kuwait, Kuwait

[5] Baghdad Med City Teaching Hosp, Baghdad, Iraq

[6] Amer Univ Beirut, Nehme & Therese Tohme Multiple Sclerosis Ctr, Med Ctr, Beirut, Lebanon

[7] Rashid Hosp, MS Dept, Dubai, U Arab Emirates

[8] Dubai Hlth Author, Dubai Med Coll, Dubai, U Arab Emirates

[9] Royal Hosp, Dept Neurol, Muscat, Oman

[10] Sultan Qaboos Univ, Neurol Unit, Dept Med, Coll Med & Hlth Sci, Muscat, Oman

[11] Sultan Qaboos Univ, Sultan Qaboos Univ Hosp, Muscat, Oman

[12] Razi Univ Hosp Mannouba, Clin Invest Ctr Neurosci & Mental Health, Dept Neurol, LR18SP03, Tunsi, Tunisia

[13] Med City, Riyadh, Saudi Arabia

[14] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah, Saudi Arabia

[15] Minist Natl Guard Hlth Affairs, Dept Neurosci, Jeddah, Saudi Arabia

[16] King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia

[17] Lebanese Univ, Fac Med Sci, Beirut, Lebanon

[18] Harley St Med Ctr, Neurol Inst, Abu Dhabi, U Arab Emirates

[19] Al Balqa Appl Univ, Fac Med, Al Salt 19117, Jordan

[20] Lebanese Univ, Fac Pharm, Beirut, Lebanon

[21] Natl Inst Publ Hlth Clin Epidemiol & Toxicol INSP, Beirut, Lebanon

[22] Lebanese Amer Univ, Sch Med, Byblos, Lebanon

[23] Univ Nicosia, Sch Med, Dept Primary Care & Populat Hlth, CY-2417 Nicosia, Cyprus

来源：

MULTIPLE SCLEROSIS JOURNAL | 2024年 / 30卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

O096/1296

引用

页码：91 / 92

页数：2

共 50 条

[41] Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study
Sorensen, Per Soelberg
Pontieri, Luigi
Joensen, Hanna
Heick, Alex
Rasmussen, Peter Vestergaard
Schafer, Jakob
Ratzer, Rikke
Pihl, Caroline Ellinore
Sellebjerg, Finn
Magyari, Melinda
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 70
[42] Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study
Lucienne Costa-Frossard França
Virginia Meca Lallana
Andrés Labiano-Fontcuberta
Rosario Blasco
Enric Monreal
María Luisa Martínez Ginés
Clara Aguirre
Julia Sabin Muñoz
Susana Sainz de la Maza
Juan Pablo Cuello
Carolina Díaz-Pérez
Juan Luis Chico García
Alberto Lozano Ros
Fernando Rodríguez Jorge
Susana Martínez Martínez
José Manuel García Domínguez
CNS Drugs, 2024, 38 : 231 - 238
[43] A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis
Trojano, Maria
Ramio-Torrenta, Lluis
Grimaldi, Luigi M. E.
Lubetzki, Catherine
Schippling, Sven
Evans, Karleyton C.
Ren, Zheng
Muralidharan, Kumar Kandadi
Licata, Stephanie
Gafson, Arie R.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (14) : 2240 - 2253
[44] Comparative efficacy of switch to natalizumab or fingolimod in active relapsing-remitting multiple sclerosis
Kalincik, T.
Horakova, D.
Spelman, T.
Jokubaitis, V.
Trojano, M.
Lugaresi, A.
Izquierdo, G.
Rozsa, C.
Grammond, P.
Alroughani, R.
Duquette, P.
Girard, M.
Pucci, E.
Lechner-Scott, J.
Slee, M.
Fernandez-Bolanos, R.
Grand'Maison, F.
Hupperts, R.
Verheul, F.
Hodgkinson, S.
Oreja-Guevara, C.
Spitaleri, D.
Barnett, M.
Terzi, M.
Bergamaschi, R.
McCombe, P.
Sanchez-Menoyo, J.
Simo, M.
Csepany, T.
Rum, G.
Boz, C.
Havrdova, E.
Butzkueven, H.
MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 195 - 196
[45] Comparative Effectiveness of Early Natalizumab Treatment in JC Virus-Negative Relapsing-Remitting Multiple Sclerosis
Campbell, Jonathan D.
McQueen, R. Brett
Miravalle, Augusto
Corboy, John R.
Vollmer, Timothy L.
Nair, Kavita
AMERICAN JOURNAL OF MANAGED CARE, 2013, 19 (04): : 278 - 285
[46] Safety and efficacy of dimethyl fumarate in a real-world relapsing-remitting multiple sclerosis population
Barros, A.
Sequeira, J.
Sousa, A.
Capela, C.
Pedrosa, R.
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 877 - 878
[47] Real-world persistence to first-line DMTs in relapsing-remitting multiple sclerosis
Lopez-Caneda, Clara
Perez-Haro, Maria Jose
Sanchez-Franco, Cesar
Alvarez-Rodriguez, Elena
Aguado-Valcarcel, Marta
Marcos-Bobillo, Maria
Gonzalez-Suarez, Ines
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 78
[48] Meta-analysis of randomized controlled trials and real-world evidence comparing natalizumab and fingolimod for relapsing-remitting multiple sclerosis
Efthimiou, O.
Acosta, C.
Saunders-Hastings, P.
Pellegrini, F.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 170 - 171
[49] Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing-remitting multiple sclerosis
Martin, Roland
CLINICAL IMMUNOLOGY, 2012, 142 (01) : 9 - 14
[50] Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Meca-Lallana, Jose E.
Gonzalez, Jose M. Prieto
Rodriguez, Ana B. Caminero
Urtaza, Javier Olascoaga
Alonso, Ana M.
Ferreras, Eduardo Duran
Espinosa, Raul
Dotor, Julio
Romera, Mercedes
Luque, Adrian Ares
Ruiz, Domingo Perez
Calles, Carmen
Hernandez, Miguel A.
Garcia, Miguel Hervas
Rodriguez, Amelia Mendoza
Montero, Yasmina Berdei
Tellez, Nieves
Varo, Nicolas Herrera
Sotoca, Javier
Presas-Rodriguez, Silvia
Gutierrez, Luis A. Querol
Pujol, Mariona Hervas
Nadal, Jordi
Ozaeta, Gisela Martin
Lillo, Laura Gubieras
Yelamos, Sergio Martinez
Ramio-Torrenta, Lluis
Frechin, Javier Mallada
Benavides, Antonio Belenguer
Gascon-Gimenez, Francisco
Casanova, Bonaventura
Pascual, Lamberto Landete
Berenguer, Leticia
Navarro, Laura
Gutierrez, Montserrat Gomez
Duran, Carmen
Regal, Ana Rodriguez
Alvarez, Elena
Garcia-Estevez, Daniel A.
Real, Ana M. Lopez
Gonzalez, Miguel A. Llaneza
Sola, Maria E. Marzo
Sanchez-Menoyo, Jose L.
Oterino, Agustin
Gonzalez, Ramon Villaverde
Castillo-Trivino, Tamara
de Arcaya, Amaya
Llarena, Cristina
NEUROLOGY AND THERAPY, 2023, 12 (06) : 2177 - 2193

← 1 2 3 4 5 →